← Eichor
Condition: Biomarkers Of Diabetic Retinopathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Biomarkers Of Diabetic Retinopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Natural Course Progression of Diabetic Retinopathy
Phase N/A · 1 location(s) · Jie Li · NCT06269419Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab
NA · 1 location(s) · Osijek University Hospital · NCT07520045Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy
Phase N/A · 2 location(s) · IRCCS Ospedale San Raffaele · NCT06582472Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment
NA · 1 location(s) · Fondazione G.B. Bietti, IRCCS · NCT07500324Biomarker of Diabetic Retinopathy
Phase N/A · 3 location(s) · Indiana University · NCT05079399Analysis of Biomarkers From Patients With Chorioretinal Diseases
Phase N/A · 1 location(s) · Kyungpook National University Hospital · NCT02026843Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients
Phase N/A · 1 location(s) · Association for Innovation and Biomedical Research on Light · NCT07458516
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.